Sifi Mexico – Juan José Davidovich, General Manager
Juan José Davidovich, general manager of the Italian ophthalmology leader Sifi, speaks about the importance of Mexico as a base to enter Latin America and sets the goal of prospering…
SIFI has made the history of ophthalmology in Italy and has worked in the eye care sector since 1935. Italian market leader for over 15 years, it develops, produces and markets innovative pharmaceutical treatments, tools for diagnosis and surgical devices for prevention and care of the most common ocular pathologies. Since its foundation in 1935, SIFI has displayed a constant commitment to working alongside ophthalmologists. Being close to practitioners, sharing their passion for EyeCare and contributing to the improvement of disease management in ophthalmology is indeed SIFI’s principal concern. The development plans for Latin America has included the constitution in 2007 of a fully owned subsidiary, Laboratorios SIFI de México, which aims to become one of the main players in the local ophthalmic pharmaceutical sector.
Contact details
SIFI de México
Dante 36, Piso 11, Oficina 1101
Col. Anzures, Del. Miguel Hidalgo
CP 11590 México DF
MÉXICO
Tel: +52 (55) 5263 2450
Website: www.sifi.it
Juan José Davidovich, general manager of the Italian ophthalmology leader Sifi, speaks about the importance of Mexico as a base to enter Latin America and sets the goal of prospering…
Consuelo Albarrán, co-founder and CEO of DEFI Latina Healthcare, showcases the increasing added value brought by this leading Cofepris-authorized third party (ATP) to the pharmaceutical industry, the recent expansion of…
Rodrigo Puga, the recently appointed general manager of Pfizer Mexico, documents his strategic priorities to further strengthen the company’s performance in Mexico and consolidate Pfizer’s leadership within the Mexican market…
General Manager of Merck Mexico, Pedro Galvis, showcases the strategic importance of the Mexican affiliate within Merck’s global network and explains the importance of public-private partnerships in enhancing patient access and…
Paulina Escobedo, general manager of B. Braun Medical Mexico, provides insights into the impressive development of this division since it was set up in the country in 2011, while the…
The university spin-off UDIBI continues its unstoppable ascension: after being recently recognized by Cofepris, Mexico’s sanitary agency, as an authorized laboratory to assess biotech treatments entering the Mexican market, UDIBI…
Alexis Serlin, country president of Novartis Mexico and president of CANIFARMA, the industry chamber that brings together multinational and local drug manufacturers, explains how the pharmaceutical industry in Mexico aims…
The General Directors of Rayere explain how the historical Mexican pharma company has been leveraging its outstanding manufacturing capacity and product development expertise to become a thriving and reputed player…
Carlos Abelleyra Cordero, CEO Spanish Latin America of Aspen Labs, describes the rapid development of Aspen’s operational capacity throughout the region, in line with the company’s ambition to ultimately establish…
Karel Fucikovsky, general director PFM Latin America at Pierre Fabre, on the strategic focus of the company on operational and commercial excellence in Mexico and Latin America, which both stand as…
In an exclusive interview, Dr. José Narro Robles, Secretary of Health of Mexico, provides insight into the main challenges of the domestic healthcare system and his strategic priorities to improve…
Takeda Mexico’s José Manuel Caamaño discusses Takeda’s impressive growth prospects in Mexico, patient-centricity, the reopening of their cutting-edge manufacturing plant in Naucalpan, and his vision to transform Takeda into one…
José Reyes Baeza Terrazas, general director of ISSSTE (Institute for Social Security and Services for State Workers) documents some of the institution’s key specificities that make it one of the…
See our Cookie Privacy Policy Here
